Association between weight-adjusted-waist index and retinopathy among American adults: a cross-sectional study and mediation analysis

被引:0
作者
Li, Junmeng [1 ]
Yin, Qianshuo [1 ]
Hao, Jianchen [1 ]
Zhu, Ruilin [1 ]
Zhang, Jing [1 ]
Zhang, Yadi [1 ]
Gu, Xiaopeng [1 ]
Wu, Zihui [1 ]
Yang, Liu [1 ]
机构
[1] Peking Univ First Hosp, Dept Ophthalmol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
WWI; retinopathy; HbA1c; NHANES (National Health and Nutrition Examination Survey); mediation analysis; DIABETIC-RETINOPATHY; ADIPOSE-TISSUE; RISK-FACTORS; METABOLIC SYNDROME; ABDOMINAL OBESITY; NATIONAL-HEALTH; INFLAMMATION; POPULATION; KIDNEY;
D O I
10.3389/fnut.2025.1556065
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Retinopathy, a microvascular complication linked to obesity and metabolic dysfunction, is characterized by the absence of reliable anthropometric predictors. The weight-adjusted waist index (WWI), incorporating waist circumference and weight, may better capture visceral adiposity and its pathological impact. This study investigates the association between WWI and retinopathy in U.S. adults and explores the potential mediating role of glycated hemoglobin (HbA1c).Methods A cross-sectional analysis was conducted on 5,572 adults aged >= 40 years from the 2005-2008 National Health and Nutrition Examination Survey (NHANES), in which retinopathy was assessed using retinal imaging. Multivariate logistic regression, restricted cubic spline models, subgroup analyses, and threshold effect analysis were used to evaluate the WWI-retinopathy relationship. Receiver operating characteristic curves (ROC) were employed to compare the predictive ability of WWI to other obesity indices. Mediation analysis assessed the role of HbA1c.Results Of 5,572 participants, 683 had retinopathy. Each unit increase in WWI was associated with a 31% higher risk of retinopathy (OR = 1.31, 95% CI: 1.16-1.48), increasing to 87% (OR = 1.87) in the highest quintile. WWI showed a dose-response relationship with retinopathy severity and consistent associations across subgroups. WWI outperformed weight, body mass index (BMI), and abdominal body shape index (ABSI) in predicting retinopathy (P < 0.05). Mediation analysis revealed that 30.02% of the WWI-retinopathy association was mediated by HbA1c (P < 0.001).Conclusion WWI serves as a stronger predictor of retinopathy than conventional obesity measures. The partial mediation by HbA1c highlights the interconnected roles of visceral fat and hyperglycemia in retinal microvascular damage.
引用
收藏
页数:12
相关论文
共 49 条
[1]  
van Leiden H.A., Dekker J.M., Moll A.C., Nijpels G., Heine R.J., Bouter L.M., Et al., Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study, Arch Ophthalmol, 121, pp. 245-251, (2003)
[2]  
Venkatramani J., Mitchell P., Ocular and systemic causes of retinopathy in patients without diabetes mellitus, BMJ, 328, pp. 625-629, (2004)
[3]  
Hendrick A.M., Gibson M.V., Kulshreshtha A., Diabetic retinopathy, Prim Care, 42, pp. 451-464, (2015)
[4]  
Harjasouliha A., Raiji V., Garcia Gonzalez J.M., Review of hypertensive retinopathy, Dis Mon, 63, pp. 63-69, (2017)
[5]  
Mbata O., Abo El-Magd N.F., El-Remessy A.B., Obesity, metabolic syndrome and diabetic retinopathy: beyond hyperglycemia, World J Diabetes, 8, pp. 317-329, (2017)
[6]  
Bluher M., Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?, Clin Sci, 130, pp. 1603-1614, (2016)
[7]  
Piche M.E., Poirier P., Lemieux I., Despres J.P., Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update, Prog Cardiovasc Dis, 61, pp. 103-113, (2018)
[8]  
Ward Z.J., Bleich S.N., Cradock A.L., Barrett J.L., Giles C.M., Flax C., Et al., Projected US state-level prevalence of adult obesity and severe obesity, N Engl J Med, 381, pp. 2440-2450, (2019)
[9]  
Man R.E.K., Sabanayagam C., Chiang P.P.C., Li L.J., Noonan J.E., Wang J.J., Et al., Differential association of generalized and abdominal obesity with diabetic retinopathy in Asian patients with type 2 diabetes, JAMA Ophthalmol, 134, pp. 251-257, (2016)
[10]  
Ouchi N., Parker J.L., Lugus J.J., Walsh K., Adipokines in inflammation and metabolic disease, Nat Rev Immunol, 11, pp. 85-97, (2011)